A prospective screen for hypercalcaemia in 58,053 hospital in-patients was conducted over 12 months. The incidence ofhypercalcaemia was 0.6%, being transient in 19.2% of patients and sustained in the remainder. The most common causes in the sustained group were malignancy (45%) and primary hyperparathyroidism (16.5%). The incidence of primary hyperparathyroidism was 78/100,000 hospital in-patients, and its discovery was directly attributable to the survey in over half the cases.
Introduction
There has been a continuing interest in the incidence of hypercalcaemia and its underlying causes. This stems both from the frequency and ease with which calcium estimations are made on routine blood analysis and the implication that hypercalcaemia may act as a marker of underlying disease. Of many causes of symptomatic and asymptomatic hypercalcaemia, primary hyperparathyroidism is a good example of a disease where repeated attempts have been made to estimate incidence and frequency. These estimates have, however, varied widely. We undertook therefore to determine, by a prospective screen, our own incidence of hypercalcaemia and the frequency distribution of its causes with particular reference to hyperparathyroidism.
Methods
A prospective screen of all hypercalcaemic hospital inpatients was undertaken over 12 non-consecutive months spanning 1983 and 1984. Groote Schuur Hospital is a general secondary and tertiary referral institution with just over 1600 beds, a major commitment to malignant disease and an active endocrine unit. A daily computer-based list of all patients with serum calcium levels in excess of 2.6 mmol/l (10.4 mg/ 100 ml) was obtained. The total serum calcium was corrected for the serum albumin using the formula (calcium + (40-albumin) x 0.025 mmol/l), and a case study opened for all in-patients. Sequential calcium values were recorded and a biochemical profile for each patient obtained. The samples were not specifically taken from fasting subjects and no attempt was made to avoid cuff occlusion as it has been shown that calcium elevation after 10 minutes is minimal and in the order of 0.1 mmol/l. ' Cases were categorized into three groups: (i) exclusions (not investigated), (ii) transient hypercalcaemia (one elevation, several normal observations) and (iii) sustained hypercalcaemia. The incidence of hypercalcaemia was calculated using both the transient and sustained cases whereas the frequency distribution of causes was estimated separately in each group.
The diagnosis of primary hyperparathyroidism was made by the clinical setting of the case, the profile of calcium, phosphate, chloride and bicarbonate on the SMAC 12/60, a 24 hour urinary calcium excretion rate and tubular resorbtion of phosphate and a discriminant analysis2 to distinguish hyperparathyroidism from other causes of hypercalcaemia.
Parathyroid hormone was assayed using a C-terminal directed radio-immunoassay (Immuno-nuclear Corporation) and nephrogenous cyclic AMP was assayed (Amersham International, United Kingdom). The clinical diagnosis was confirmed at surgery in symptomatic patients and the young.
For purposes of comparison all previous studies324 were ordered chronologically and the proportions of exclusions and transient hypercalcaemics were recalculated where appropriate.
Results
There were 350 patients with hypercalcaemia detected over the 12 month period. During this time there were 58,053 hospital admissions. We have excluded 12 hypercalcaemic patients as they had been discharged after a single investigation and could not be followed up. We therefore calculate our incidence to be 0.6% (338/58,053) of hospital admissions.
Transient hypercalcaemia
In 65 patients (19.2%) there was only one calcium elevation and more than two normal levels ( Table I ). In 29 of these patients the hypercalcaemia occurred during an acute cardiac event (cardiac surgery, myocardial infarction and cardiopulmonary resuscitation) or during the course of calcium infusion, (6) parenteral nutrition, (5) hyperosmolar diabetic coma (4) and pre-eclamptic toxaemia (2) . In 19 instances we found no explanation for the phenomenon.
Sustained hypercalcaemia
The frequency distribution of causes was calculated in the 273 patients with sustained hypercalcaemia. The most common causes were malignant disease (45%), thiazide diuretic administration (21%) and primary hyperparathyroidism (17%); less common causes were renal disease, rhabdomyolysis, thyrotoxicosis, sarcoidosis and lithium therapy. In 13 patients (4%) the sustained hypercalcaemia remains obscure; in most of these the investigations were suggestive but not conclusive of hyperparathyroidism but neck exploration has not been undertaken for this reason and for concomitant frailty.
The primary sites of malignancy were grouped into organ systems (Table II) . As such, the lung was the most common site (30%) followed by urogenital (15%), gastrointestinal (13%), haematological (12%), head and neck (10%), breast (8%) and unknown primary site (8%). The mean level of serum calcium was 3.15 ± 0.52 mmol/l (range 2.6-4.95) and was higher in patients with overt bone metastases (3.27 ± 0.61 mmol/l) than those without (3.08 ± 0.46 mmol/l), but not statistically significant. Follow up was complete in 81 patients ofwhom only 7 are alive, the mean survival time being 78 days (range 1-518 days).
We made the diagnosis of primary hyperparathyroidism in 45 patients. We therefore calculated our incidence of primary hyperparathyroidism amongst hypercalcaemic patients to be 16.5% (45/338) and our incidence amongst hospital in-patients to be 0.078% (45/58053). In 21 patients the possible diagnosis of primary hyperparathyroidism had been made by the attending clinician and in the remaining 25 the diagnosis was directly attributable to the survey. Fifteen of the undiagnosed group were symptomatic, the manifestations of hypercalcaemia being renal stones (3), confusional state (3), pancreatitis (2), peptic ulcer (2), polymyalgia (1) and various combinations of these (4) . The diagnosis of primary hyperparathyroidism was proven in each of the 27 cases where neck exploration was undertaken. In the remaining 19 patients neck exploration was not undertaken due to one or a combination of patient refusal, advanced age, severe concomitant disease or mild hypercalcaemia. Malignant disease accounted for 45% of our causes of sustained hypercalcaemia and was also the most common cause in most analyses, the average frequency being 38.5% (Table IV) . This contrasted to Christensson's figure of 2% of apparently normal adults who harboured malignant disease when found to be hypercalcaemic during a health screening programme.'4"5 Our major primary sites of malignancy were the lung, gastrointestinal and urogenital tracts, haematological, head and neck and breast which was essentially similar to those reported by others.
Primary hyperparathyroidism accounted for 16 .5% of our cases. The average proportion was 25% in hospital series and 71% in the health screen reported by Christensson.'4"5 It was noteworthy that the discovery of over half our cases of primary hyperparathyroidism was directly attributable to the survey; not 25 We did not encounter hypervitaminosis D or the milk alkali syndrome and the decreasing incidence of the last two causes must be due to an alteration in prescribing patterns over the years surveyed.
Our incidence of primary hyperparathyroidism was 16.5% of hypercalcaemiac patients. The reported incidence amongst hypercalcaemics varies widely (Table V) : the highest incidences were 71.5% of an apparently normal population'4"5 and 35.5% in a series before automated analyses when estimations were probably mainly problem orientated.3 We calculated an average of 22.5% of hypercalcaemic patients in hospital had primary hyperparathyroidism when we combined our proportion with other hospital series.
When we calculated our incidence as a proportion of hospital patients we found this to be 0.78% or 78/ 100,000. Once again we found a wide variation in estimates but calculated an average hospital incidence with a renal stone clinic excluded3 of 0.19% or 190/ 100,000. Christensen's is the only study of which we are aware in apparently normal adults and his incidence was 0.52% or 52/100,000.'4"' Our major concern was that occult primary hyperparathyroidism could be overlooked and true incidences underestimated if a significant proportion of cases were dismissed as transient, obscure or uninvestigated. We decided that our 12 uninvestigated cases should be excluded; others investigating the incidence and causes of hypercalcaemia have also recorded exclusions and in some instances these were significant in number (Table IV) .
As many as 19% of our patients had transient hypercalcaemia and in most instances we were able to find a cause such as therapy during an acute cardiac event, parenteral nutrition or calcium infusion. In 19 instances, however, we had no explanation for the phenomenon. In none of the unexplained group did the calcium exceed 3.0 mmol/l, and all had only a (Table IV) . In conclusion we found an incidence of hypercalcaemia of 0.6% of 58,053 hospital in-patients which fell within the range of 0.2-1.36% of the reports we surveyed. Where malignancy and endocrine disorders predominate an incidence of 3-5% could be expected and confirmation of the incidence in the apparently normal population is required. Malignancy accounted for 45% of our causes of sustained hypercalcaemia, the average reported frequency being 38.5%. Our incidence ofprimary hyperparathyroidism was 16 .5% (or 78/100,000) and the discovery of many cases was directly attributable to the survey; the average of previous reports was 22.5% (or 190/100,000). 
